alanosine and Skin-Neoplasms

alanosine has been researched along with Skin-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for alanosine and Skin-Neoplasms

Article	Year
Phase II evaluation of L-alanosine (NSC-153353) for patients with disseminated malignant melanoma. American journal of clinical oncology, 1984, Volume: 7, Issue:5 The authors conducted a phase II study of L-alanosine in 39 patients (19 without prior chemotherapy) in advanced malignant melanoma. The intravenous dose was 250 mg/m2/days 1-3 repeated at 3-week intervals. There were two objective regressions (5%) in conjunction with generally transient and tolerable hematologic and gastrointestinal toxicity. L-alanosine as used in our study has limited activity against malignant melanoma. Topics: Alanine; Antibiotics, Antineoplastic; Drug Evaluation; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Skin Neoplasms	1984

Article

Year

Phase II evaluation of L-alanosine (NSC-153353) for patients with disseminated malignant melanoma.

American journal of clinical oncology, 1984, Volume: 7, Issue:5

The authors conducted a phase II study of L-alanosine in 39 patients (19 without prior chemotherapy) in advanced malignant melanoma. The intravenous dose was 250 mg/m2/days 1-3 repeated at 3-week intervals. There were two objective regressions (5%) in conjunction with generally transient and tolerable hematologic and gastrointestinal toxicity. L-alanosine as used in our study has limited activity against malignant melanoma.

Topics: Alanine; Antibiotics, Antineoplastic; Drug Evaluation; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Skin Neoplasms

1984